The role of semaphorin 3A in the pathogenesis and progression of Alzheimer’s disease and other aging-related diseases: A comprehensive review

The role of semaphorin 3A in the pathogenesis and progression of Alzheimer’s disease and other aging-related diseases: A comprehensive review

Aging serves as a pivotal factor in the etiology of numerous diseases, such as Alzheimer's disease (AD), Parkinson's disease, diabetes, osteoarthritis, atherosclerosis and aging-related macular degeneration. Notably, these diseases often interact with AD through various pathways, facilitat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiayu Yuan, Rui Huang, Jianfei Nao, Xiaoyu Dong
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Pharmacological Research
Subjects:	Semaphorin 3 A Alzheimer’s disease Parkinson’s disease Atherosclerosis Type 2 diabetes mellitus
Online Access:	http://www.sciencedirect.com/science/article/pii/S1043661825001574
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis
by: Jacob M. Pfaffinger, et al.
Published: (2025-08-01)

Assessment of Serum Semaphorin-3A Level in Systemic Lupus Erythematosus Patients in Suez Canal Region
by: Alaa Saber Shams, et al.
Published: (2022-01-01)

Knocking down hypoxia-induced Semaphorin 6B may attenuate the progression of cervical cancer through regulating macrophage M2 polarization
by: Shuyan Yi, et al.
Published: (2025-07-01)

Prosaposin: A Multifaceted Protein Orchestrating Biological Processes and Diseases
by: Xin Li, et al.
Published: (2025-07-01)

Expression analysis and possible functional roles of semaphorin/plexin/CRMP families in mouse pancreatic islets
by: Mayu Kyohara, et al.
Published: (2025-03-01)

Integrative analysis of semaphorins family genes in colorectal cancer: implications for prognosis and immunotherapy
by: Jiahao Zhu, et al.
Published: (2025-03-01)

Semaphorin7A patterns neural circuitry in the lateral line of the zebrafish
by: Agnik Dasgupta, et al.
Published: (2024-08-01)

Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2
by: Hironao Nakayama, et al.
Published: (2025-03-01)

Application of optical coherence tomography in neurodegenerative diseases: a focus on Parkinson’s, Alzheimer’s, and Schizophrenia in Bulgarian patients
by: Alina Y. Levi, et al.
Published: (2024-12-01)

The Role of Immune Semaphorins in Sepsis—A Prospective Cohort Study
by: Branimir Gjurasin, et al.
Published: (2024-12-01)

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer’s Disease and Parkinson’s Disease
by: Jung YH, et al.
Published: (2025-04-01)

Serum Levels of Semaphorin 4C in Breast Cancer – Assessment of Prognostic Value and Potential for Monitoring Surgical Treatment Response
by: Popov Ts., et al.
Published: (2024-12-01)

Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer’s and Parkinson’s disease
by: Sofia Toniolo, et al.
Published: (2025-05-01)

Semaphorin4B is elevated in rheumatoid arthritis and enhances the inflammatory phenotype of macrophages and fibroblast-like synoviocytes
by: Sara Martínez-Ramos, et al.
Published: (2025-07-01)

A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis
by: Qiong Pan, et al.
Published: (2021-09-01)

piRNAs in neurodegenerative diseases: Mechanisms of pathogenesis and therapeutic potential
by: Jheremy Sebastian Reyes Barreto, et al.
Published: (2025-05-01)

Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions
by: Julia Doroszkiewicz, et al.
Published: (2025-04-01)

Semaphorin 3F is elevated in serum of heart failure patients and inhibits cardiac angiogenesis via the VEGF/Akt/eNOS pathway
by: Diana Petrova, et al.
Published: (2025-09-01)

VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin‐1+ monocyte/TGF‐β1 paracrine axis
by: Elena Groppa, et al.
Published: (2015-09-01)

Mitotherapy in Alzheimer’s and Parkinson’s diseases: A systematic review of preclinical studies
by: Aynur Modiri, et al.
Published: (2025-05-01)

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
by: Chengyong Liu, et al.
Published: (2025-01-01)

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
by: Nidhi Puranik, et al.
Published: (2025-02-01)

Adherence to a Mediterranean Diet and Risks of Alzheimer and Parkinson Diseases: A Systematic Review of Population-Based Studies
by: Sukshma Sharma, et al.
Published: (2023-11-01)

Assessment of causality association between serum adiponectin levels and the risk of Alzheimer’s disease and Parkinson’s disease: a Mendelian randomization study
by: Jiali Lin, et al.
Published: (2025-04-01)

Relationship Testosterone with the development of Alzheimer's disease in men with diabetes
by: Asra'a I. Al-Taii, et al.
Published: (2023-01-01)

Alzheimer’s disease pathogenesis and risk factors
by: A. Gerulytė, et al.
Published: (2019-12-01)

Pathogenesis of Alzheimer disease
by: Pavlović Dragan M., et al.
Published: (2007-01-01)

Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
by: Eleftheria-Emmanouela Katsoulaki, et al.
Published: (2025-06-01)

Functional analysis and signaling pathway enrichment analysis of genes associated with Alzheimer’s disease and Parkinson’s disease
by: N. Yu. Chasovskikh, et al.
Published: (2020-04-01)

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
by: Nicoleta-Mirela Blebea, et al.
Published: (2025-06-01)

Identification of shared mechanisms between Alzheimer's disease and atherosclerosis by integrated bioinformatics analysis
by: Jukun Wang, et al.
Published: (2025-05-01)

Ambient Air Pollution and Parkinson’s Disease and Alzheimer’s Disease: An Updated Meta-Analysis
by: Cuiyao Xie, et al.
Published: (2025-02-01)

The mechanism of super-enhancer regulation of gene expression and research progress in neurodegenerative diseases
by: Shaofei Zhao, et al.
Published: (2025-04-01)

NFκB1: a common biomarker linking Alzheimer's and Parkinson's disease pathology
by: Adam Cunningham, et al.
Published: (2025-05-01)

Neuroprotective effects of essential oils in animal models of Alzheimer’s and Parkinson’s disease: a systematic review
by: Adrielle do Espírito Santos Macedo, et al.
Published: (2025-07-01)

Telemedicine Use Before and During the COVID-19 Pandemic in People with Alzheimer’s Disease, Multiple Sclerosis, or Parkinson’s Disease: A Cross-Sectional Study Using US Commercial Claims Data
by: Anisha M. Patel, et al.
Published: (2024-04-01)

Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort
by: Ha-Lim Jeon, et al.
Published: (2025-07-01)

Role of Microbiota-Derived Hydrogen Sulfide (H<sub>2</sub>S) in Modulating the Gut–Brain Axis: Implications for Alzheimer’s and Parkinson’s Disease Pathogenesis
by: Constantin Munteanu, et al.
Published: (2024-11-01)

Microbiome Dysbiosis as a Driver of Neurodegeneration: Insights into Alzheimer’s and Parkinson’s Diseases
by: Ana Jagodic, et al.
Published: (2025-04-01)

Semaphorin 3E‐Plexin‐D1 Pathway Downstream of the Luteinizing Hormone Surge Regulates Ovulation, Granulosa Cell Luteinization, and Ovarian Angiogenesis in Mice
by: Hanxue Zhang, et al.
Published: (2025-08-01)